Clinicopathological response assessment to neoadjuvant chemotherapy in locally advanced breast cancer- A rural population-based case series
Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 44
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JCOMS-3-2_001
تاریخ نمایه سازی: 14 آذر 1402
Abstract:
Introduction:
Breast cancer is the commonest malignancy among women worldwide. Despite a multidisciplinary
approach, locally advanced breast cancer remains a clinical challenge as most of the patient s have a high rate of
locoregional spread and develop distant metastases. Neoadjuvant chemotherapy not only paves the way for a more
conservative surgical option but also decreases the incidence of positive nodes. This study was undertaken , t o assess
the effectiveness of neo adjuvant chemotherapy and its impact on clinical and pathological response in locally
advanced breast cancer. It also, compare patient characte ristics, histological type, and hormonal receptor status with
response to neo adjuvant chemotherapy chemotherapy.
Materials and Methods: This is a prospective observational study over a one year period on ۳۰ locally advanced
breast cancer patients from rural background who received neoadjuvant chemotherapy. All patients received a standard
neoadjuvant treatment regimen and were ev aluated clinically, radiologically, and pathologically pre and post
chemotherapy. The clinical response was assessed by RECIST criteria, the pathological response was graded according
to Chevalier classification, and the overall impact was assessed by AJC C response criteria
Results:
Most of the patients (۴۶.۷%) were in the age group of ۳۵ ۴۸ years. The premenopausal and postmenopausal
groups were ۶۳% and ۳۷%, respectively. In the present study, tumours expressing oestrogen, progesterone, and HER
۲ were ۷۳%, ۶۶%, and ۲۷%, respectively. Patients showing clinically compl ete responses post neoadjuvant
chemotherapy were ۴, partial responses were ۲۱, stable disease was ۳, and progressive disease was ۲. A pathological
partial response was achieved in ۹۳% of patients
Conclusion:
Neoadjuvant chemotherapy in locally advanced breast cancer not only downstages the disease but
increases the scope of operability and thus makes it possible to resect the disease with a tumour free margin in most
cases.
Keywords:
Locally advanced breast cancer (LABC) , Neoadjuvant chemotherapy (NACT)
Authors
Kailash Kumar Thakuria
Kokrajhar Medical College and hospital, Assam, India
Sushmita Ray
Fakhruddin Ali Ahmed Medical College and hospital, Barpeta, Assam, India
Rahul Sarma
Fakhruddin Ali Ahmed Medical College and hospital, Barpeta, Assam, India